JAK2 mutant has been described in several cases with myeloproliferative neoplasms (MPNs) polycythemia Vera, thrombocythemia, myelofibrosis, and also a high level of STAT3 has been detected in special ovarian cancer cell lines (Nowak et al., 2017). This evidence concerns the gene JAK2 and acquired polycythemia vera.